Transfer Clause Example from Business Contracts

This example Transfer clause appears in 13 contracts from 5 companies

Transfer. Subject to compliance with applicable federal and state securities laws, this Warrant and the Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent of the Company.
Found in Syros Pharmaceuticals, Inc. contract
Syros Pharmaceuticals, Inc. Contracts

Syros Pharmaceuticals, Inc. Class A Warrant to Purchase Common Stock (Filed With SEC on April 8, 2019)

DYNAVAX TECHNOLOGIES CORP Contracts

Dynavax Technologies Corporation Warrant to Purchase Common Stock (August 12, 2019) (Filed With SEC on August 8, 2019)

BELLICUM PHARMACEUTICALS, INC Contracts

Underwriting Agreement for Series 1 Preferred Stock and Warrants – Bellicum Pharmaceuticals, Inc. and Underwriters (Jefferies LLC, Wells Fargo Securities, LLC) (Filed With SEC on August 19, 2019)

Bellicum Pharmaceuticals, Inc. Warrant to Purchase Common Stock or Series 1 Preferred Stock (August 21, 2019) (Filed With SEC on August 19, 2019)

Bellicum Pharmaceuticals, Inc. Warrant to Purchase Common Stock or Series 1 Preferred Stock (Filed With SEC on August 19, 2019)

Bellicum Pharmaceuticals, Inc. Warrant to Purchase Common Stock (November 2020) (Filed With SEC on November 2, 2020)

Bellicum Pharmaceuticals, Inc. Warrant to Purchase Common Stock (December 2021) (Filed With SEC on December 6, 2021)

Arsanis, Inc. Contracts

X4 Pharmaceuticals, Inc. Class B Warrant to Purchase Common Stock (Form of Warrant) (Filed With SEC on November 27, 2019)

IDERA PHARMACEUTICALS, INC. Contracts

Idera Pharmaceuticals, Inc. Warrant to Purchase Common Stock or Series B1 Preferred Stock (Filed With SEC on December 23, 2019)

Idera Pharmaceuticals, Inc. Pre-Funded Warrant to Purchase Common Stock (2020) (Filed With SEC on April 7, 2020)

Idera Pharmaceuticals, Inc. Warrant to Purchase Common Stock (2020–2023) (Filed With SEC on April 7, 2020)

Idera Pharmaceuticals, Inc. Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on July 15, 2020)

Idera Pharmaceuticals, Inc. Warrant to Purchase Common Stock (2020-2023) (Filed With SEC on July 15, 2020)